Acquisition of Aquarius Biotechnologies, Inc. (Details 1) - USD ($) |
Sep. 30, 2015 |
Jan. 29, 2015 |
Dec. 31, 2014 |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Business Acquisition [Line Items] | ||||||||||
Goodwill | $ 1,384,674 | $ 0 | ||||||||
Net assets acquired | $ 2,873,035 | |||||||||
Aquarius Biotechnologies, Inc. [Member] | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Cash | 70,754 | |||||||||
Contract/ Grant receivable | 45,644 | |||||||||
Prepaid expenses and other current assets | 5,084 | |||||||||
Equipment, net | 5,051 | |||||||||
Other assets | 700 | |||||||||
In-process research and development | [1] | 3,017,377 | ||||||||
Total identifiable assets | 3,144,610 | |||||||||
Accounts payable | 300,413 | |||||||||
Notes payable | [2] | 10,000 | ||||||||
Accrued expenses | 92,509 | |||||||||
Total liabilities assumed | 402,922 | |||||||||
Net identifiable assets acquired | 2,741,688 | |||||||||
Goodwill | [3] | 1,384,674 | ||||||||
Deferred income taxes arising from basis differences of tax aspects of in-process research and development | (1,253,327) | |||||||||
Net assets acquired | $ 2,873,035 | |||||||||
|